SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950115-99-000888
Filing Date
1999-06-14
Accepted
1999-06-14 00:00:00
Documents
4
Period of Report
1999-04-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT 10-Q 45020
2 AGREEMENT AND PLAN OF MERGER EX-2.1 5664
3 CERTIFICATE OF INCORPORATION EX-3.1 14649
4 FDS EX-27 2235
  Complete submission text file 0000950115-99-000888.txt   69283
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 99645422
SIC: 2834 Pharmaceutical Preparations